CSIR- National Chemical Laboratory developed NP swabs for Covid19 sample collection. It is an appropriately small size for paediatric, nasopharyngeal or urethral genital sample collection. Approved by ICMR, the technology has been licensed to Ms. Chembond Polymers and Materials Pvt. Ltd. (CPML), Mumbai. CPML has now started commercial manufacturing of these nasal swabs under the name, Kemylon Swabs. The company has established a facility to produce 1 lakh swabs per day.
Recent Posts
MagVenture introduces MagVenture Flow Arm for non-invasive brain stimulation
MagVenture, the Danish medical device company behind MagVenture TMS Therapy, introduces the MagVenture Flow Arm — a patent-pending, clinical positioning system to optimize the...
Sikkim gets India’s 2nd largest government hospital
The people of Sikkim will be able to access free state-sponsored healthcare in the new 10-storied Sir Thutob Namgyal Memorial Multi-Speciality Hospital (STNM) in...
ROBOTIC SURGERY FOR CANCER PATIENTS – OPPORTUNITIES & CHALLENGES
For a long time, cancer has been treated with conventional open surgery that left patients with pain and prolonged recovery. However, the advent of robotics has completely transformed this space. - Dr Sandeep Nayak
RevBio receives $2 Million to pursue the treatment of wrist fractures with its Tetranite
RevBio patented bone adhesive technology known as Tetranite is injectable by creating a small incision in a patient's skin to deliver the material, making it a more minimally invasive treatment option.
Artificial Intelligence Corroborates COVID-19 treatment
The collaboration between Prof. Angshul Majumdar of IIIT Delhi and Prof. Emilie Chouzenoux of INRIA, Saclay, Paris, harnesses the power of deep learning to...